Literature DB >> 14688073

Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response.

Hidekazu Tamauchi1, Masazumi Terashima, Mamoru Ito, Hiroko Maruyama, Nobunao Ikewaki, Matsuhisa Inoue, Xiuhua Gao, Katsuto Hozumi, Sonoko Habu.   

Abstract

The transcription factor GATA-3 has been shown to play an important role for the in vitro induction of T(h)2 cells. To clarify how the in vivo immune response is governed under GATA-3 function, we generated double-transgenic mice by crossing GATA-3 transgenic mice with ovalbumin (OVA)-specific TCR transgenic mice. After immunization with OVA, the double-transgenic mice showed increased expression of GATA-3 in antigen-reactive fresh CD4(+) T cells, and higher production of IL-5 and IL-13 in cultured spleen cells in the presence of cognate antigen without any polarizing conditions for T(h)2 cells. Moreover, the immunized double-transgenic mice showed a higher increase of in vivo secretion of IL-5 and IL-13 in bronchoalveolar lavage fluid after OVA aerosol challenging. The serum levels of OVA-specific IgG1, IgE and IgA antibodies were much higher in the immunized double-transgenic mice than TCR transgenic mice. These findings provide direct evidence that antigen-stimulated CD4(+) T cells in the immunized mice have already been committed into T(h)2 cells producing IL-5 and IL-13 selectively through enhanced GATA-3 expression in vivo, thereby inducing higher production of antigen-specific antibody for three isotypes other than IgM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688073     DOI: 10.1093/intimm/dxh026

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  The differential expression of IL-4 and IL-13 and its impact on type-2 immunity.

Authors:  Katherine Bao; R Lee Reinhardt
Journal:  Cytokine       Date:  2015-06-11       Impact factor: 3.861

2.  Increased Risk of Atopic Diseases in the Siblings of Patients with Autism Spectrum Disorder: A Nationwide Population-Based Cohort Study.

Authors:  Ying-Xiu Dai; Ying-Hsuan Tai; Yun-Ting Chang; Tzeng-Ji Chen; Mu-Hong Chen
Journal:  J Autism Dev Disord       Date:  2019-11

Review 3.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

4.  LXR-mediated inhibition of CD4+ T helper cells.

Authors:  Laura A Solt; Theodore M Kamenecka; Thomas P Burris
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

5.  The mediatory role of Majie cataplasm on inflammation of allergic asthma through transcription factors related to Th1 and Th2.

Authors:  Wenting Ji; Qianyi Zhang; Hanfen Shi; Ruijuan Dong; Dongyu Ge; Xin Du; Beida Ren; Xueqian Wang; Qingguo Wang
Journal:  Chin Med       Date:  2020-05-24       Impact factor: 5.455

6.  Blockade of thymic stromal lymphopoietin and CRTH2 attenuates airway inflammation in a murine model of allergic asthma.

Authors:  Hea Yon Lee; Hwa Young Lee; Jung Hur; Hye Seon Kang; Joon Young Choi; Chin Kook Rhee; Ji Young Kang; Young Kyoon Kim; Sook Young Lee
Journal:  Korean J Intern Med       Date:  2020-03-19       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.